Js Capital Management LLC Editas Medicine, Inc. Transaction History

Js Capital Management LLC

  • $210 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$19.43 - $26.41 $4.25 Million - $5.78 Million
-218,935 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$27.65 - $38.39 $2.07 Million - $2.88 Million
75,000 Added 52.11%
218,935 $6.97 Million
Q2 2018

Aug 14, 2018
BUY
$31.4 - $41.01 $4.52 Million - $5.9 Million
143,935 New
143,935 $5.16 Million

Others Institutions Holding EDIT

# of Institutions
228
Shares Held
54.2M
Call Options Held
412K
Put Options Held
355K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $95.5M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Js Capital Management LLC Portfolio

Follow Js Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Js Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Js Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email